Consonance Capital Management LP Mustang Bio, Inc. Transaction History

Consonance Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.57 - $4.08 $8.12 Million - $12.9 Million	-3,160,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.74 - $4.65 $589,100 - $999,750	-215,000 Reduced 6.37%	3,160,000 $10.3 Million
Q2 2019 Aug 14, 2019	BUY	$2.66 - $6.28 $8.98 Million - $21.2 Million	3,375,000 New	3,375,000 $12.4 Million

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.